Morgan Stanley’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.83M Sell
529,376
-869,606
-62% -$7.93M ﹤0.01% 4087
2025
Q1
$11.1M Sell
1,398,982
-3,195,373
-70% -$25.4M ﹤0.01% 3238
2024
Q4
$24.9M Buy
4,594,355
+3,785,557
+468% +$20.6M ﹤0.01% 2549
2024
Q3
$5.84M Sell
808,798
-581,902
-42% -$4.2M ﹤0.01% 3851
2024
Q2
$15.1M Buy
1,390,700
+134,255
+11% +$1.46M ﹤0.01% 2967
2024
Q1
$23.5M Sell
1,256,445
-484,683
-28% -$9.08M ﹤0.01% 2519
2023
Q4
$37.7M Buy
1,741,128
+877,196
+102% +$19M ﹤0.01% 2743
2023
Q3
$17.8M Buy
863,932
+512,021
+145% +$10.5M ﹤0.01% 2584
2023
Q2
$16.5M Sell
351,911
-20,741
-6% -$975K ﹤0.01% 2665
2023
Q1
$15.6M Sell
372,652
-130,983
-26% -$5.5M ﹤0.01% 2694
2022
Q4
$19.2M Buy
503,635
+162,920
+48% +$6.21M ﹤0.01% 2383
2022
Q3
$13.3M Sell
340,715
-232,585
-41% -$9.11M ﹤0.01% 2647
2022
Q2
$18.5M Buy
573,300
+8,178
+1% +$264K ﹤0.01% 2378
2022
Q1
$18.7M Buy
565,122
+276,594
+96% +$9.15M ﹤0.01% 2196
2021
Q4
$12.3M Sell
288,528
-46,312
-14% -$1.97M ﹤0.01% 2711
2021
Q3
$14.8M Sell
334,840
-242,876
-42% -$10.8M ﹤0.01% 2418
2021
Q2
$32.8M Buy
577,716
+330,541
+134% +$18.8M ﹤0.01% 1660
2021
Q1
$18.5M Buy
247,175
+87,826
+55% +$6.57M ﹤0.01% 1995
2020
Q4
$13.8M Sell
159,349
-106,380
-40% -$9.2M ﹤0.01% 2185
2020
Q3
$16.2M Buy
265,729
+113,109
+74% +$6.91M ﹤0.01% 1633
2020
Q2
$6.35M Sell
152,620
-840,235
-85% -$34.9M ﹤0.01% 2430
2020
Q1
$28.5M Buy
992,855
+908,546
+1,078% +$26.1M 0.01% 1051
2019
Q4
$6.09M Buy
84,309
+20,914
+33% +$1.51M ﹤0.01% 2978
2019
Q3
$8.89M Sell
63,395
-31,482
-33% -$4.42M ﹤0.01% 2246
2019
Q2
$17.4M Buy
94,877
+13,104
+16% +$2.4M ﹤0.01% 1597
2019
Q1
$13M Sell
81,773
-4,789
-6% -$762K ﹤0.01% 1783
2018
Q4
$8.29M Sell
86,562
-8,603
-9% -$824K ﹤0.01% 2325
2018
Q3
$13.4M Sell
95,165
-25,704
-21% -$3.63M ﹤0.01% 2099
2018
Q2
$18.9M Sell
120,869
-38,267
-24% -$5.99M 0.01% 1697
2018
Q1
$25.6M Sell
159,136
-34,019
-18% -$5.48M 0.01% 1443
2017
Q4
$31.8M Buy
193,155
+135,592
+236% +$22.3M 0.01% 1291
2017
Q3
$3.59M Buy
57,563
+7,190
+14% +$448K ﹤0.01% 3314
2017
Q2
$4.01M Buy
50,373
+1,047
+2% +$83.4K ﹤0.01% 3092
2017
Q1
$3.51M Sell
49,326
-48,267
-49% -$3.43M ﹤0.01% 3256
2016
Q4
$4.98M Buy
97,593
+76,016
+352% +$3.88M ﹤0.01% 2998
2016
Q3
$993K Sell
21,577
-50,211
-70% -$2.31M ﹤0.01% 4044
2016
Q2
$2.16M Buy
71,788
+62,280
+655% +$1.88M ﹤0.01% 3360
2016
Q1
$304K Buy
9,508
+1,953
+26% +$62.4K ﹤0.01% 4729
2015
Q4
$440K Sell
7,555
-884
-10% -$51.5K ﹤0.01% 4629
2015
Q3
$357K Sell
8,439
-10,301
-55% -$436K ﹤0.01% 4792
2015
Q2
$1.37M Buy
18,740
+12,137
+184% +$886K ﹤0.01% 3960
2015
Q1
$331K Buy
6,603
+4,642
+237% +$233K ﹤0.01% 4921
2014
Q4
$72K Buy
1,961
+116
+6% +$4.26K ﹤0.01% 5686
2014
Q3
$58K Buy
+1,845
New +$58K ﹤0.01% 5678